Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer - 29/11/25
, Littisha Lawrance b, c, 1, Lama Dawi a, b, Jules Dupont a, b, Othilie Gautier b, Michèle Kind d, Samy Ammari a, b, Joya Hadchiti a, Aurélie Choucair a, b, Arnaud Bayle e, f, Paul-Henry Cournède g, n, Isabelle Borget f, h, Serge Muller a, b, François Bidault a, b, f, Corinne Balleyguier a, b, Antoine Hollebecque e, i, Yohann Loriot e, f, Filippo Gustavo Dall-Olio i, Benjamin Besse f, i, Ludovic Lacroix j, Etienne Rouleau k, Alexandre Bône c, Fabrice André f, i, n, Christophe Massard e, f, Fabrice Barlesi f, i, Antoine Italiano e, l, m, n, Nathalie Lassau a, b, f, nHighlight |
• | Combining baseline CT tumor burden with liquid biopsy may improve the prediction of outcomes and help anticipate follow-up care strategies in patients with metastatic solid cancer. |
• | CT tumor burden helps stratify patients with metastatic solid cancer and undetectable circulating tumor deoxyribonucleic acid at baseline. |
• | CT tumor burden and circulating tumor deoxyribonucleic acid from liquid biopsy are prognostic factors for overall survival in patients with metastatic solid cancer. |
Abstract |
Purpose |
The purpose of this study was to evaluate baseline tumor burden from liquid biopsy (LB) and computed tomography (CT) as prognostic biomarkers and whether their combination refines stratification in metastatic solid cancers.
Materials and methods |
This retrospective cohort study included 1065 patients. Eligible patients underwent LB and chest-abdomen-pelvis CT examination at baseline. Radiologists outlined lesions on the largest axial slice, and total tumor volume (TTV) was approximated in three dimensions. LB Tumor fraction (TF) ≥ 10 % was considered high. To assess combined prognostic power of LB and TTV, patients were divided into three groups according to LB (circulating tumor deoxyribonucleic acid [ctDNA] detectability and TF) and each group was further divided into two subgroups using TTV thresholds determined by Youden’s index. Overall survival (OS) analyses were performed using Cox proportional hazard models and Kaplan-Meier curves.
Results |
A total of 560 patients (290 women and 270 men; median age, 61 years) with 31,314 annotated lesions were selected. The median OS was 11.28 months, and the median TTV was 96.68 cm 3 . The LB groups included patients with undetectable ctDNA ( n = 102), patients with detectable ctDNA and low TF ( n = 251), and patients with high TF ( n = 207). Integrating TTV thresholds (18.7 cm 3 , 44.9 cm 3 , and 159.94 cm 3 ) to LB groups significantly stratified the population on OS. Patients with undetectable ctDNA and TTV ≥ 18.7 cm 3 had significantly shorter OS (median OS, 24.8 months) than those with TTV < 18.7 cm 3 (median OS, > 35 months).
Conclusion |
Combining baseline CT tumor burden with LB could be a valuable prognostic tool for stratifying patients with metastatic solid cancer.
Le texte complet de cet article est disponible en PDF.Keywords : Biomarkers, Computed tomography, Liquid biopsy, Prognosis, Tumor burden
Abbreviations : cfDNA, ctDNA, CI, CT, HR, LB, MSI-H, OS, TTV, TF
Plan
Vol 106 - N° 12
P. 430-437 - décembre 2025 Retour au numéro
Article précédent
- Color K-edge angiography with a dedicated gadolinium-based contrast agent for spectral photon-counting computed tomography
- Christian Alejandro Hernandez-Fajardo, François Lux, Tristan Doussineau, Sandrine Dufort, Jean-Baptiste Langlois, Angele Houmeau, Agnieszka Gutwinska, Ramata Seydou Coulibaly, Antoine Robert, Geraldine Le Duc, Olivier Tillement, Philippe Douek, Salim Si-Mohamed
- Contribution of a new super-resolution deep-learning image reconstruction algorithm coupled with an extended matrix to cardiac CT image quality
- Joël Greffier, Djamel Dabli, Fabien de Oliveira, Jean-Paul Beregi, Mickaël Ohana
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?